Axsome Therapeutics Inc (NASDAQ: AXSM) kicked off on Friday, down -3.60% from the previous trading day, before settling in for the closing price of $71.73. Over the past 52 weeks, AXSM has traded in a range of $55.02-$98.40.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Healthcare Sector giant saw their annual sales surged by 88.16% over the last five years. While this was happening, its average annual earnings per share was recorded 29.88%. With a float of $38.78 million, this company’s outstanding shares have now reached $47.35 million.
The firm has a total of 545 workers. Let’s measure their productivity.
Axsome Therapeutics Inc (AXSM) Breakdown of a Key Holders of the stock
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Axsome Therapeutics Inc is 18.14%, while institutional ownership is 80.85%. The most recent insider transaction that took place on Apr 01 ’24, was worth 1,904,942. In this transaction Chief Operating Officer of this company sold 24,662 shares at a rate of $77.24, taking the stock ownership to the 0 shares. Before that another transaction happened on Mar 15 ’24, when Company’s Director sold 2,347 for $71.61, making the entire transaction worth $168,062. This insider now owns 120,756 shares in total.
Axsome Therapeutics Inc (AXSM) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.77 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 29.88% per share during the next fiscal year.
Axsome Therapeutics Inc (NASDAQ: AXSM) Trading Performance Indicators
Take a look at Axsome Therapeutics Inc’s (AXSM) current performance indicators. Last quarter, stock had a quick ratio of 3.52. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 12.11.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -5.20, a number that is poised to hit -1.18 in the next quarter and is forecasted to reach 0.73 in one year’s time.
Technical Analysis of Axsome Therapeutics Inc (AXSM)
Analysing the last 5-days average volume posted by the [Axsome Therapeutics Inc, AXSM], we can find that recorded value of 0.58 million was lower than the volume posted last year of 0.74 million. As of the previous 9 days, the stock’s Stochastic %D was 15.85%. Additionally, its Average True Range was 3.29.
During the past 100 days, Axsome Therapeutics Inc’s (AXSM) raw stochastic average was set at 29.92%, which indicates a significant increase from 5.60% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 32.36% in the past 14 days, which was lower than the 50.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $80.43, while its 200-day Moving Average is $74.94. Now, the first resistance to watch is $71.53. This is followed by the second major resistance level at $73.91. The third major resistance level sits at $75.53. If the price goes on to break the first support level at $67.52, it is likely to go to the next support level at $65.90. Now, if the price goes above the second support level, the third support stands at $63.52.
Axsome Therapeutics Inc (NASDAQ: AXSM) Key Stats
The company with the Market Capitalisation of 3.28 billion has total of 47,374K Shares Outstanding. Its annual sales at the moment are 270,600 K in contrast with the sum of -239,240 K annual income. Company’s last quarter sales were recorded 71,530 K and last quarter income was -98,650 K.
